PARTNER WITH US TO ADVANCE CRITICAL CARE INNOVATION

Partnering to strengthen infection management in hospitals, emergency care, and
high-risk civilian healthcare settings.

SEEKING STRATEGIC PARTNERS

Investment and collaboration opportunities are available for the development of advanced antibiotics to combat flesh-eating bacteria and associated application technologies.

 

  • Investment Partner: Supporting the development, formulation, and preclinical testing of next-generation antibiotics targeting high-risk, drug-resistant infections.
  • Collaboration Partner: Engaging in clinical validation and deployment in emergency care, hospital settings, and other high-intensity civilian healthcare environments.

Contact Us

InnoStudio Inc.
genoveva.filipcsei@innostudio.org

ThalesNano Inc.
g.darvas@thalesnano.com

Privacy Overview
Treat On Site

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Google Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Powered by  GDPR Cookie Compliance